Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Hematology|July 24, 2026
Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patientsEmi Yokoyama, Taisuke Harada, Tomoyuki Endo, et al.
International Journal of Hematology|March 8, 2011
Loss of ABCB7 gene: pathogenesis of mitochondrial iron accumulation in erythroblasts in refractory anemia with ringed sideroblast with isodicentric (X)(q13)Kazuya Sato, Yoshihiro Torimoto, Takaaki Hosoki, et al.
International Journal of Hematology|October 18, 2019
Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphomaReiji Fukano, Tetsuya Mori, Naoto Fujita, et al.
British Journal of Haematology|July 9, 2002
A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remissionJun Ooi, Tohru Iseki, Satoshi Takahashi, et al.
European Journal of Clinical Pharmacology|October 29, 2015
Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemiaYoji Ishida, Kazunori Murai, Kohei Yamaguchi, et al.
International Journal of Hematology|July 2, 2013
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study GroupYoshihiro Torimoto, Kazuya Sato, Katsuya Ikuta, et al.
Blood Neoplasia|June 2, 2025
KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational studyHiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, et al.
European Journal of Haematology|April 17, 2018
Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemiaShuichi Ota, Toshihiro Matsukawa, Satoshi Yamamoto, et al.
European Journal of Haematology|September 13, 2017
Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patientsKazunori Murai, Kohei Yamaguchi, Shigeki Ito, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 12, 2016
A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/LymphomaSatoshi Iyama, Tsutomu Sato, Hirofumi Ohnishi, et al.
Pageof 7